• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过免疫组织化学、流式细胞术和抗原受体重排的聚合酶链反应确定犬淋巴瘤的免疫表型。

Lymphoma immunophenotype of dogs determined by immunohistochemistry, flow cytometry, and polymerase chain reaction for antigen receptor rearrangements.

作者信息

Thalheim L, Williams L E, Borst L B, Fogle J E, Suter S E

机构信息

Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC.

出版信息

J Vet Intern Med. 2013 Nov-Dec;27(6):1509-16. doi: 10.1111/jvim.12185. Epub 2013 Sep 20.

DOI:10.1111/jvim.12185
PMID:24112291
Abstract

BACKGROUND

Immunohistochemistry (IHC), flow cytometry (FC), and PCR for antigen receptor rearrangements (PARR) are 3 widely utilized tests to determine immunophenotype in dogs with lymphoma (LSA).

OBJECTIVES

This study evaluated the ability of FC and PARR to correctly predict immunophenotype as defined by IHC and to determine the level of agreement among the 3 tests.

ANIMALS

Sixty-two dogs with lymphoma.

METHODS

Retrospective study. Medical records were searched to identify dogs with LSA that had concurrent IHC, FC, and PARR performed. Immunophenotype results were categorized as B-cell, T-cell, dual immunophenotype (B- and T-cell), or indeterminate. The results of FC and PARR were evaluated for correctly classifying B- and T-cell LSA as compared with IHC. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were evaluated in addition to concordance between each test.

RESULTS

The sensitivity of FC was significantly higher than PARR for both B-cell (91% versus 67%; P < 0.0072) and T-cell (100% versus 75%; P < 0.0312) LSA. The percent agreement between FC and IHC was 94%, between PARR and IHC was 69%, between FC and PARR was 63%, and among all 3 tests was 63%.

CONCLUSIONS AND CLINICAL IMPORTANCE

Flow cytometry is superior to PARR in correctly predicting immunophenotype when evaluating lymph nodes from dogs already diagnosed with B- or T-cell LSA. If fresh samples are not available for FC, PARR is an acceptable assay for determination of immunophenotype given its high specificity.

摘要

背景

免疫组织化学(IHC)、流式细胞术(FC)以及抗原受体重排聚合酶链反应(PARR)是用于确定淋巴瘤犬免疫表型的3种广泛应用的检测方法。

目的

本研究评估FC和PARR正确预测由IHC定义的免疫表型的能力,并确定这3种检测方法之间的一致性水平。

动物

62只淋巴瘤犬。

方法

回顾性研究。检索病历以确定同时进行了IHC、FC和PARR检测的淋巴瘤犬。免疫表型结果分为B细胞型、T细胞型、双免疫表型(B细胞和T细胞)或不确定型。将FC和PARR的结果与IHC进行比较,评估其对B细胞型和T细胞型淋巴瘤的正确分类能力。除了评估每种检测方法之间的一致性外,还评估了敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。

结果

对于B细胞型淋巴瘤(91%对67%;P < 0.0072)和T细胞型淋巴瘤(100%对75%;P < 0.0312),FC的敏感性均显著高于PARR。FC与IHC之间的一致性百分比为94%,PARR与IHC之间为69%,FC与PARR之间为63%,所有3种检测方法之间为63%。

结论及临床意义

在评估已确诊为B细胞型或T细胞型淋巴瘤犬的淋巴结时,流式细胞术在正确预测免疫表型方面优于PARR。如果没有新鲜样本用于FC检测,鉴于PARR具有较高的特异性,它是一种可接受的免疫表型检测方法。

相似文献

1
Lymphoma immunophenotype of dogs determined by immunohistochemistry, flow cytometry, and polymerase chain reaction for antigen receptor rearrangements.通过免疫组织化学、流式细胞术和抗原受体重排的聚合酶链反应确定犬淋巴瘤的免疫表型。
J Vet Intern Med. 2013 Nov-Dec;27(6):1509-16. doi: 10.1111/jvim.12185. Epub 2013 Sep 20.
2
Minimal residual disease detection by flow cytometry and PARR in lymph node, peripheral blood and bone marrow, following treatment of dogs with diffuse large B-cell lymphoma.采用流式细胞术和聚合酶链反应受体重排(PARR)检测弥漫性大B细胞淋巴瘤犬治疗后淋巴结、外周血和骨髓中的微小残留病。
Vet J. 2014 May;200(2):318-24. doi: 10.1016/j.tvjl.2014.03.006. Epub 2014 Mar 31.
3
Polymerase chain reaction for antigen receptor rearrangement: Benchmarking performance of a lymphoid clonality assay in diverse canine sample types.用于抗原受体重排的聚合酶链反应:不同犬类样本类型中淋巴细胞克隆性检测的性能基准测试
J Vet Intern Med. 2019 May;33(3):1392-1402. doi: 10.1111/jvim.15485. Epub 2019 Apr 2.
4
Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies.用于检测犬类淋巴恶性肿瘤克隆性的抗原受体重排(PARR)检测的聚合酶链反应(PCR)的优化与验证
Vet Immunol Immunopathol. 2016 Dec;182:115-124. doi: 10.1016/j.vetimm.2016.10.008. Epub 2016 Oct 19.
5
Composition of lymphocyte subpopulations in normal canine lymph nodes.正常犬淋巴结中淋巴细胞亚群的组成
Vet Clin Pathol. 2015 Mar;44(1):58-69. doi: 10.1111/vcp.12221. Epub 2014 Dec 15.
6
Flow-cytometric detection of phenotypic aberrancies in canine small clear cell lymphoma.犬小细胞淋巴瘤表型异常的流式细胞术检测
Vet Comp Oncol. 2015 Sep;13(3):281-7. doi: 10.1111/vco.12043. Epub 2013 May 31.
7
Utility of polymerase chain reaction for analysis of antigen receptor rearrangement in staging and predicting prognosis in dogs with lymphoma.聚合酶链反应在犬淋巴瘤分期及预后预测中分析抗原受体重排的应用
J Vet Intern Med. 2006 Mar-Apr;20(2):329-34. doi: 10.1892/0891-6640(2006)20[329:uopcrf]2.0.co;2.
8
Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.通过流式细胞术检测犬淋巴瘤不同亚型中的异常表型和定量抗原表达。
Vet Immunol Immunopathol. 2008 Feb 15;121(3-4):179-88. doi: 10.1016/j.vetimm.2007.09.018. Epub 2007 Oct 2.
9
Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.犬淋巴瘤/白血病的谱系分化及CD分子的异常表达
Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):179-96. doi: 10.1016/j.vetimm.2005.02.020.
10
Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma.应用流式细胞术免疫表型分析对犬淋巴瘤的细胞学诊断进行细化。
Vet J. 2011 May;188(2):149-55. doi: 10.1016/j.tvjl.2010.03.011. Epub 2010 Apr 21.

引用本文的文献

1
Clonal T Cell Proliferation Induced by Acute Anaplasmosis in a Dog.犬急性无形体病诱导的克隆性T细胞增殖
J Vet Intern Med. 2025 Sep-Oct;39(5):e70233. doi: 10.1111/jvim.70233.
2
Identification of novel genetic mutations for the treatment prognostication of canine lymphoma.鉴定用于犬淋巴瘤治疗预后的新型基因突变。
NPJ Precis Oncol. 2025 Jun 12;9(1):174. doi: 10.1038/s41698-025-00988-5.
3
Diagnosis and Classification of Primary Nodal Lymphomas in Dogs: A Consensus of the Oncology-Pathology Working Group.犬原发性淋巴结淋巴瘤的诊断与分类:肿瘤病理学工作组共识
Vet Comp Oncol. 2025 Sep;23(3):331-345. doi: 10.1111/vco.13064. Epub 2025 May 19.
4
Pilot Study of a Novel First-Line Protocol (THOP) for Intermediate-Large B-Cell Lymphoma in Dogs.犬中大型B细胞淋巴瘤新型一线治疗方案(THOP)的初步研究
Vet Sci. 2025 Mar 6;12(3):251. doi: 10.3390/vetsci12030251.
5
Classification and Prognostication of B-Cell and T-Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs.利用血清微小RNA对犬B细胞和T细胞多中心淋巴瘤进行分类和预后评估
Vet Comp Oncol. 2025 Jun;23(2):310-319. doi: 10.1111/vco.13057. Epub 2025 Apr 5.
6
Sequential transcriptome profiling: comparative analysis of normal and canine lymphoma preceding detailed T-cell and B-cell subtype comparison.连续转录组分析:在详细的T细胞和B细胞亚型比较之前对正常犬和犬淋巴瘤进行的比较分析。
Front Vet Sci. 2025 Jan 22;11:1473421. doi: 10.3389/fvets.2024.1473421. eCollection 2024.
7
Evaluation of Serum YKL-40 in Canine Multicentric Lymphoma: Clinical and Diagnostic Implications.犬多中心淋巴瘤中血清YKL-40的评估:临床及诊断意义
Animals (Basel). 2024 Nov 25;14(23):3391. doi: 10.3390/ani14233391.
8
Diagnosis of canine B-cell chronic lymphoid leukemia with a CD21 negative phenotype using the LT21 clone CD21 antibody in flow cytometry: a case report.应用 LT21 克隆 CD21 抗体流式细胞术检测犬 CD21 阴性表型 B 细胞慢性淋巴细胞白血病:一例报告。
BMC Vet Res. 2024 Oct 26;20(1):490. doi: 10.1186/s12917-024-04335-x.
9
Analysis of the Prevalence of Canine Splenic Mass Lesions in Republic of Korea via Histopathological Diagnosis with Immunohistochemistry.通过免疫组织化学组织病理学诊断分析韩国犬脾脏肿物病变的患病率
Vet Sci. 2023 Mar 25;10(4):247. doi: 10.3390/vetsci10040247.
10
Epigenetic Alterations in Canine Malignant Lymphoma: Future and Clinical Outcomes.犬恶性淋巴瘤的表观遗传改变:未来与临床结果
Animals (Basel). 2023 Jan 29;13(3):468. doi: 10.3390/ani13030468.